Kensey Nash makes first bone void filler shipment
Medical technology company Kensey Nash Corp. (Nasdaq: KNSY) said this morning that it shipped its first product kit of its bone void filler OsseoFit Porous Tissue Matrix to Biomet Sports Medicine, Inc., the sports medicine subsidiary of Biomet Inc.
The product kit will be used to expand the clinical use of the OsseoFit device beyond a select group of sites that have had access to the product to date.
According to Kensey Nash, preliminary surgeon response to its OsseoFit Porous Tissue Matrix product has been very positive and the small cap said additional product that is being sent out for commercial distribution will allow greater surgeon and clinical exposure.
OsseoFit Porous Tissue Matrix is an implant manufactured from Kensey Nash's Porous Tissue Matrix technology, which creates foamed scaffolds suited for tissue engineering applications.
Shares of Kensey Nash (KNSY) were halted in pre-market trading.
